Latest Asx Market Activity News

Monash IVF has received a revised $0.90 per share acquisition proposal from a consortium led by Genesis Capital and WHSP Holdings, upping the ante from a previous $0.80 offer. The deal hinges on exclusivity and unanimous board support, with no guarantee of completion.

Kjerulf David Hastings Ainsworth has issued a first supplementary statement for his second off-market takeover bid targeting 5.5% of Ainsworth Game Technology shares at $1.30 each, revealing an 8.24% voting stake ahead of the offer’s close.

Duxton Farms Limited has initiated an on-market share buyback program, aiming to repurchase up to 10% of its issued capital to support liquidity and enhance shareholder returns.

Viridis Mining and Minerals Limited has had its trading suspension lifted following its response to media speculation and an ASX price and volume query.

Capricorn Metals Ltd’s CMMO securities have been reinstated to trading on the ASX after meeting compliance requirements, signaling renewed market activity. Investors will be watching closely to gauge the impact on liquidity and price movement.

Greenvale Energy Ltd has had its trading suspension lifted immediately following the release of a capital raise announcement, signaling renewed market activity for the energy company.

Peninsula Energy Limited has had its ASX trading suspension lifted following the completion of a placement and institutional entitlement offer, signaling renewed market activity.

Ramelius Resources has completed its acquisition of Spartan Resources through a court-approved scheme, issuing new shares that start deferred trading ahead of normal settlement next week.

Challenger Gold Limited has had its trading suspension lifted immediately following its announcement on capital raising activities, signaling renewed market activity.

Metrics Master Income Trust (MXT) has successfully completed a $315 million wholesale placement, boosting its portfolio diversification and increasing its net asset value to approximately $2.44 billion.

Generation Development Group has successfully closed its institutional equity raising, securing $233.3 million to fund the strategic acquisition of Evidentia Group Holdings. Strong investor demand underscores confidence in GDG’s growth trajectory.

Cleo Diagnostics has responded to an ASX price query following a notable rise in its share price and trading volume, underscoring its patented ovarian cancer detection technology and ongoing U.S. clinical trials.